Latest Partnerships News

Leo Lithium Limited reports a robust cash position of $269.3 million following the sale of a 40% stake in MLBV, underpinning its financial strength amid ongoing operational expenditures.

Strategic Elements Ltd reports a robust cash position and progress across its portfolio of early-stage ventures, including the promising Energy Ink™ technology and autonomous vehicle applications in mining.

Advanced Health Intelligence Ltd has locked in a USD$4 million convertible note facility with UAE-based KOR Investments LLC, aiming to raise up to AUD$10 million to fuel its MENA expansion and reduce debt.

Hastings Technology Metals has secured a strategic non-binding MOU with Saudi Arabia’s Ministry of Investment to explore a rare earths processing facility, while reporting encouraging developments at its Yangibana Project and maintaining solid financial footing.

European Lithium Limited has made significant strides in Q4 2024, acquiring the Leinster Lithium Project in Ireland and reporting promising high-grade rare earth results from its Greenland drilling program.

Focus Minerals Ltd. reported record ore processing at its Three Mile Hill plant and significant progress on the Bonnie Vale Underground Mine during the December 2024 quarter, supported by a solid cash position of $16.5 million.

High Peak Royalties has fully repaid its US$750,000 financing facility with Macquarie Bank, removing all associated securities and guarantees. The company signals confidence in its near-term liquidity and operational funding.

Jameson Resources Limited has made significant progress in environmental approvals for its Crown Mountain Hard Coking Coal Project, while community and political backing for the coal sector in Canada strengthens. The company plans to resubmit its Environmental Impact Statement by mid-2025.

Equity Story Group Ltd (ASX:EQS) reports a robust December quarter marked by significant growth in funds under management, membership fees, and capital markets revenue, alongside strategic cost reductions positioning the company for sustained 2025 growth.

Codeifai Limited has terminated its exclusive licence with MIT and launched a strategic review of its material science division, signaling a decisive pivot towards digital and AI-driven brand solutions.

Avecho Biotechnology progresses its Phase III clinical trial for a TPM®-enhanced CBD insomnia capsule, expands patient recruitment, and completes a major manufacturing campaign for its U.S. partner Ashland.

BlinkLab has launched its pivotal FDA registrational study for its AI-driven autism diagnostic app, BlinkLab Dx 1, following positive FDA feedback and promising preliminary results.